← Browse by Condition
Medical Condition
solid tumors phase 1
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT07288957 Phase 1
Recruiting
A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors
Enrollment
266 pts
Location
China
Sponsor
Abbisko Therapeutics Co, Ltd
NCT07252479 Phase 1
Recruiting
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
Enrollment
91 pts
Location
United States
Sponsor
Adlai Nortye Biopharma Co., Lt...